FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Novocure Phase 3 Study Misses Primary Endpoint

Novocure says its Phase 3 ENGOT-ov50/GOG-3029/INNOVATE-3 clinical trial of Tumor Treating Fields together with paclitaxel in patients with platinum-re...

latest-news-card-1
Federal Register

Final Guide on Product Tracing Enforcement

Federal Register notice: FDA makes available a final guidance entitled Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the...

latest-news-card-1
Human Drugs

Enforcement Deferred on Drug Security Needs

FDA posts a guidance on new enforcement deferments affecting enhanced drug distribution security requirements.

latest-news-card-1
FDA General

Inmar Recalls Products Due to Rodent Infestation

Inmar Supply Chain Solutions recalls FDA-regulated products (over-the-counter (OTC) human or animal drugs, OTC medical devices, dietary supplements, f...

latest-news-card-1
Human Drugs

Comments Sought on Pepaxtos Proposed Withdrawal

CDER asks for comments on its proposal to withdraw Oncopeptides accelerated-approved multiple myeloma drug Pepaxto (melphalan flufenamide).

latest-news-card-1
Medical Devices

CDRH Qualifies Tool on Material Biostability

CDRH announces the qualification of a new tool through the agencys voluntary Medical Device Development Tools program: Accelerated Testing to Prove Lo...

Medical Devices

Fresenius Home Hemodialysis Guide Cleared

FDA clears a Fresenius Medical Care 510(k) for VersiHD with GuideMe Software, a self-guided interface for the companys VersiHD chronic home hemodialys...

latest-news-card-1
Human Drugs

Redx Orphan Status for Pulmonary Fibrosis

FDA grants Redx an orphan drug designation for zelasudil (RXC007) for treating idiopathic pulmonary fibrosis.

latest-news-card-1
Medical Devices

FDA Updates HeartWare Device Alert

Medtronic issues an Urgent Medical Device Communication about its HeartWare Ventricular Assist Device (HVAD) systems and a newly identified subgroup o...

latest-news-card-1
Human Drugs

Merck, Eisai Stop LEAP-010 Trial

Merck and Eisai terminate the Phase 3 LEAP-010 trial evaluating Mercks Keytruda (pembrolizumab) plus Eisais Lenvima (lenvatinib) in the first-line tre...